Adaptin Bio (APTN) EBIT (2023 - 2026)
Adaptin Bio's (APTN) quarterly EBIT came in at -$1.2 million in Q2 2026, up 21.06% year-over-year from -$991781.4 in Q2 2025, and down 4.93% quarter-over-quarter from -$1.1 million in Q1 2026.
Powered by 
Analysis
Adaptin Bio (APTN) EBIT (2023 - 2026) Analysis & Trends
Adaptin Bio has disclosed EBIT across 4 years of filings, most recently posting -$1.2 million for Q2 2026.
- In Q2 2026, EBIT rose 21.06% year-over-year to -$1.2 million; the TTM figure through Jun 2026 stood at -$5.4 million (down 39.09% YoY), while the FY2025 annual figure was -$5.4 million, down 110.71% from the prior year.
- EBIT came in at -$1.2 million for Q2 2026 at Adaptin Bio, down from -$1.1 million in the prior quarter.
- In the past five years, EBIT ranged from a high of -$34155.0 in Q4 2023 to a low of -$1.7 million in Q3 2025.
- Average EBIT over 4 years is -$867224.2, with a median of -$922603.5 recorded in 2024.
- Year-over-year, EBIT plunged 2216.71% in 2024 and advanced 21.06% in 2026.
- Over 4 years, EBIT stood at -$34155.0 in 2023, then plunged by 1387.57% to -$508080.0 in 2024, then plunged by 169.25% to -$1.4 million in 2025, then rose by 12.24% to -$1.2 million in 2026.
- Per Business Quant data, the three most recent EBIT figures were -$1.2 million in Q2 2026, -$1.1 million in Q1 2026, and -$1.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.26 Bn | 9.41 Bn | 112.79 Mn | 58.42 Mn |
| 2 | CRISPR Therapeutics AG | 5.19 Bn | 5.19 Bn | - | -117.27 Mn |
| 3 | Iovance Biotherapeutics | 3.76 Bn | 3.46 Bn | 55.72 Mn | -51.91 Mn |
| 4 | Legend Biotech | 3.67 Bn | 2.71 Bn | 251.50 Mn | 57.70 Mn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | -52.20 Mn |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - | -126.55 Mn |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | 22.64 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.54 Bn | 251.87 Mn | 13.29 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 434,000.00 |
| 10 | Adaptin Bio | 56.76 Mn | 56.09 Mn | - | -1.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.20 Mn |
| Mar 31, 2026 | -1.14 Mn |
| Dec 31, 2025 | -1.37 Mn |
| Sep 30, 2025 | -1.68 Mn |
| Jun 30, 2025 | -1.52 Mn |
| Mar 31, 2025 | -850,458.00 |
| Dec 31, 2024 | -508,080.00 |
| Sep 30, 2024 | -994,749.00 |
| Jun 30, 2024 | -767,320.00 |
| Mar 31, 2024 | -299,736.00 |
| Dec 31, 2023 | -34,155.00 |
| Sep 30, 2023 | -42,938.00 |